Literature DB >> 8698849

IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.

R L Palmer-Crocker1, C C Hughes, J S Pober.   

Abstract

IL-4 and IL-13 each act on human endothelial cells (ECs) to induce expression of vascular cell adhesion molecule-1. On hematopoietic cells. IL-4 responses may be mediated either through a pathway involving gc, the common signaling subunit of the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors, or through a gc-independent pathway that may be alternatively activated by IL-13. We find that human ECs do not express gc, as detected by indirect immunofluorescence and FACS analysis or by a reverse transcription-PCR method. Like IL-4, IL-13 activates a protein tyrosine kinase that phosphorylates the IL-4R binding protein. In addition, we find that IL-4 and IL-13 each induce tyrosine phosphorylation of the JAK2 tyrosine kinase. Furthermore, both IL-4 and IL-13 induce binding of the Stat6 transcription factor to a consensus sequence oligonucleotide. We conclude that the IL-4 response of human ECs involves the IL-13 shared pathway that is independent of gc, and uses JAK2-Stat6 signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698849      PMCID: PMC507467          DOI: 10.1172/JCI118829

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells.

Authors:  B J Rollins; J S Pober
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.

Authors:  M H Thornhill; D O Haskard
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

3.  Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.

Authors:  D J Matthews; P A Clark; J Herbert; G Morgan; R J Armitage; C Kinnon; A Minty; K H Grabstein; D Caput; P Ferrara
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

4.  IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals.

Authors:  R Moser; J Fehr; P L Bruijnzeel
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

5.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.

Authors:  A Minty; P Chalon; J M Derocq; X Dumont; J C Guillemot; M Kaghad; C Labit; P Leplatois; P Liauzun; B Miloux
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

6.  Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.

Authors:  A N McKenzie; J A Culpepper; R de Waal Malefyt; F Brière; J Punnonen; G Aversa; A Sato; W Dang; B G Cocks; S Menon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha.

Authors:  E M Paleolog; G R Aluri; M Feldmann
Journal:  Cytokine       Date:  1992-11       Impact factor: 3.861

8.  Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells.

Authors:  R A Swerlick; K H Lee; L J Li; N T Sepp; S W Caughman; T J Lawley
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

9.  IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells.

Authors:  L M Wang; A D Keegan; W E Paul; M A Heidaran; J S Gutkind; J H Pierce
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1.

Authors:  R P Schleimer; S A Sterbinsky; J Kaiser; C A Bickel; D A Klunk; K Tomioka; W Newman; F W Luscinskas; M A Gimbrone; B W McIntyre; B S Bochner
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

View more
  22 in total

Review 1.  Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation.

Authors:  A Ray; L Cohn
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.

Authors:  Bart van Hartingsveldt; Ivo P Nnane; Esther Bouman-Thio; Matthew J Loza; Alexa Piantone; Hugh M Davis; Kevin J Petty
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

3.  Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.

Authors:  M Goebeler; B Schnarr; A Toksoy; M Kunz; E B Bröcker; A Duschl; R Gillitzer
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Selective enhancement of endothelial cell VCAM-1 expression by interleukin-10 in the presence of activated leucocytes.

Authors:  C Fiehn; E M Paleolog; M Feldmann
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

Review 5.  Proinflammatory Pathways in the Pathogenesis of Asthma.

Authors:  R Stokes Peebles; Mark A Aronica
Journal:  Clin Chest Med       Date:  2019-03       Impact factor: 2.878

Review 6.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

Review 7.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

8.  Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.

Authors:  Maho Suzukawa; Marina Miller; Peter Rosenthal; Jae Youn Cho; Taylor A Doherty; Ajit Varki; David Broide
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

9.  An immune cell-selective interleukin 4 agonist.

Authors:  A B Shanafelt; C P Forte; J J Kasper; L Sanchez-Pescador; M Wetzel; R Gundel; J M Greve
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3.

Authors:  Bo Xu; Ashish Bhattacharjee; Biswajit Roy; Hong-Min Xu; David Anthony; David A Frank; Gerald M Feldman; Martha K Cathcart
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.